Echo IQ is trading 5.16% down now at A$1.47 after closing at A$1.55 on August 6, 2026; possible profit-taking after the recent rally remains unconfirmed.

  • No company-specific announcement dated August 6–10 has been identified to explain the decline.
  • The latest notable news was the August 5 formal FDA 510(k) submission for EchoSolv HF, which available coverage does not directly link to the August 10 decline.
  • The broader market was broadly flat, offering little evidence of a macro-driven move.